AU9190098A - Detection of minimal residual disease in lymphoid malignancies - Google Patents

Detection of minimal residual disease in lymphoid malignancies

Info

Publication number
AU9190098A
AU9190098A AU91900/98A AU9190098A AU9190098A AU 9190098 A AU9190098 A AU 9190098A AU 91900/98 A AU91900/98 A AU 91900/98A AU 9190098 A AU9190098 A AU 9190098A AU 9190098 A AU9190098 A AU 9190098A
Authority
AU
Australia
Prior art keywords
detection
residual disease
minimal residual
lymphoid malignancies
malignancies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU91900/98A
Other languages
English (en)
Inventor
Martha Jacoba Pongers-Willemse
Jacobus Johannes Maria Van Dongen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Erasmus University Rotterdam
Original Assignee
Erasmus University Rotterdam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erasmus University Rotterdam filed Critical Erasmus University Rotterdam
Publication of AU9190098A publication Critical patent/AU9190098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU91900/98A 1997-09-18 1998-09-18 Detection of minimal residual disease in lymphoid malignancies Abandoned AU9190098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97202858 1997-09-18
EP97202858 1997-09-18
PCT/NL1998/000542 WO1999014366A2 (fr) 1997-09-18 1998-09-18 Detection d'une pathologie residuelle minime dans des tumeurs malignes lymphoides

Publications (1)

Publication Number Publication Date
AU9190098A true AU9190098A (en) 1999-04-05

Family

ID=8228734

Family Applications (1)

Application Number Title Priority Date Filing Date
AU91900/98A Abandoned AU9190098A (en) 1997-09-18 1998-09-18 Detection of minimal residual disease in lymphoid malignancies

Country Status (4)

Country Link
EP (1) EP1015635A2 (fr)
AU (1) AU9190098A (fr)
CA (1) CA2303945A1 (fr)
WO (1) WO1999014366A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3103140A1 (fr) * 2018-06-11 2019-12-19 Monoquant Pty Ltd Procede d'amplification

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7762091A (en) * 1990-03-30 1991-10-30 City Of Hope Detection of minimal residual disease in lymphoid malignancies
AU9147991A (en) * 1990-11-28 1992-06-25 University Of Texas System, The Methods and compositions for detecting and quantitating hematopoietic tumors
US5538848A (en) * 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
CA2219891C (fr) * 1995-05-05 2002-01-29 Applied Biosystems, Llc Procedes et reactifs pour combiner une amplification par reaction en chaine de la polymerase et une technique de sondage par hybridation
ATE215610T1 (de) * 1995-07-27 2002-04-15 Dalgety Plc Verfahren zur bestimmung des hautfärbung-genotyps eines schweins

Also Published As

Publication number Publication date
WO1999014366A3 (fr) 1999-05-06
WO1999014366A2 (fr) 1999-03-25
CA2303945A1 (fr) 1999-03-25
EP1015635A2 (fr) 2000-07-05

Similar Documents

Publication Publication Date Title
AU1618697A (en) Novel compounds and pharmaceutical use thereof
AU8127998A (en) Quinoline compounds and medicinal uses thereof
AU9790198A (en) Compounds and methods
AU9646198A (en) Isoquinoline derivative and drug
AU5518098A (en) Body waste detection and alarm system
HUP0001971A3 (en) Soluble ctla4 mutant molecules and uses thereof
AU7762091A (en) Detection of minimal residual disease in lymphoid malignancies
AU1585999A (en) Methods for the detection and treatment of disease using a glycosyltransferase
IL133784A0 (en) Dolastatin 15 derivatives
AU8548498A (en) Enhanced detection method
AU3673497A (en) Detection of microbacteria
AU1390999A (en) Methods for detection of mutations in myostatin variants
AU4035997A (en) Improvements relating to event detection and recordal
GB2317296B (en) Detection of scratches
AU4668196A (en) Detection of mutations or variations in dna
EP1032559A4 (fr) Derives d'amino-alkylphenols et composes associes
GB2332529B (en) Detection
AU8271998A (en) Methods of disease detection
AU5697996A (en) Peptidyl compounds and their therapeutic use
AU1877497A (en) Quinoxaline derivatives useful in therapy
AU6520198A (en) Quinolinomorphinane derivatives and medicinal use thereof
ZA987425B (en) Phenylethanolaminotetralin derivatives and bronchodilators
AU6727598A (en) In vitro determination for detection of tumors of the intestine
ZA988065B (en) Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
AU3459595A (en) Improvements in detection means

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase